Trials / Completed
CompletedNCT02786810
Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- University of Tennessee · Academic / Other
- Sex
- All
- Age
- 8 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The study will be evaluating the efficacy and safety of a contrast drug in pediatric renal ultrasound.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sulfur hexafluoride type-a lipid microspheres | Used as a contrast to enhance renal ultrasound |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2016-11-01
- Completion
- 2016-11-01
- First posted
- 2016-06-01
- Last updated
- 2018-05-11
- Results posted
- 2018-04-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02786810. Inclusion in this directory is not an endorsement.